- bulk
Supplier Type
- Manufacturer
- Trader
- contract manufacturer
- custom synthesis
- Reagent
Supplier Region
- Bangalore(3)
- Gujarat(29)
- Maharashtra(35)
- New Delhi(6)
- Hyderabad(46)
- Pune(7)
- Beijing(2)
- Mumbai(64)
- Karnataka(7)
- Andhra Pradesh(4)
- Delhi(12)
- Ahmedabad(11)
- Tamil Nadu(1)
- Telangana(4)
- Haryana(3)
- Vadodara(9)
- Punjab(1)
- Uttar Pradesh(2)
- Madhya Pradesh(3)
- Kerela(1)
- Ujjain(1)
- Kolkata(1)
Purity
- Salicylic Acid
- Rasagiline Mesylate Impurity C
- Purity By Gc Nlt 98%
- NMR
- NLT 95%
- NLT 90.00%
- NLT 90%
- N/A
- more than 95%
- more than 90%
- min 99%
- Mesalazine EP Impurity H
- Mathadone (M225865) impurity. Used in synthesis of methadone, antispasmodics and other pharmaceutica
- Greater than 99%
- good
- Dipropargyl r- amino indane
- API Impurity / In-house working standard
- Acetylsalicylic Acid EP Impurity C
- ABOVE 99%
- 99.99
- 99.98%
- 99.97%
- 99.95%
- 99.91%
- 99.90%
- >99.9%
- 99.9%
- 99.9
- 99.86%
- 99.85%
- 99.80 %
- 99.8%
- 99.73%
- 99.72%
- 99.59%
- 99.51%
- 99.5%+
- 99.5%
- 99.5 %
- 99.42%
- 99.40%
- 99.34%
- 99.33%
- 99.30%
- 99.29%
- 99.26%
- 99.21%
- 99.20%
- 99.18%
- 99.05%
- 99.04%
- 99.00%
- 99%+
- 99% Minimum
- 99% Min
- 99% ABOVE
- >99%
- 99%
- 99 %
- 99
- 98+
- 98.97%
- 98.46%
- 98.22%
- 98.12%
- 98.00%
- >98.0%
- 98.0 %
- 98%+
- 98% min
- 98% +
- 98%
- >98%
- 98 %
- 98 - 99 %
- 97-99%
- 97.25%
- 97.00%
- 97%
- >97%
- 97 to 98
- 97 %
- 96.80%
- 96.39%
- 96.00%
- 96% - 98%
- 96%
- 95-99%
- 95-98%
- 95.00%
- 95% & 97%
- 95%
- >95%
- 95
- 94.00%
- 94%
- 92.64%
- >92%
- >90%
- 90%
- 90 % Above
- 600
- 25 MG 50 MG 100 MG 250 MG EXTRA
- 15%/23%/33%
- 15%/20%/23%/30% & 1.6M
- 100%
- 1.8M
- 1.0M/3.0M
- 1.0M/2.0M
- 1.0M
- 0.7M in
- (R)-N,N-di(prop-2-yn-1-yl)-2,3- dihydro-1
Package
- 25mg
- 50mg
- 100mg
- 1g
- 2.5501e+00925 MG 50 MG 100 MG 250 MG EXTRA
- 0MG TO GRAM
- 250mg
- 500mg
- 1000mg
- 1gm
- 5g
- 10g
- 25g
- 50g
- 100ml
- 100gm
- 100g
- 500g
- 500ml
- 500gm
- 1L
- 1kg
- 5kg
- 10kg
- 25kg
- 50kg
- 100kg
- 500kg
- 1000Kg
- 1MT
- 1and gm
- 95NLT %
- 250250 mg.
-
Levothyroxine Related Compound (2-Acetamido-3-(4-acetoxy-3,5-diiodophenyl)propanoic Acid)
153324-21-1
-
N-Acetyl-L-thyroxine Ethyl Ester
30804-52-5
-
N-Acetyl L-Thyroxine
26041-51-0
-
3-PiperidinaMine, 1-acetyl-N,4-diMethyl-N-1H-pyrrolo[2,3-d]pyriMidin-4-yl-, (3R,4R)- (9CI)
477600-76-3
-
L-Tyrosine, N-acetyl-L-cysteinyl-L-cysteinyl-L-α-glutamyl-L-tyrosyl-L-cysteinyl-L-cysteinyl-L-asparaginyl-L-prolyl-L-alanyl-L-cysteinyl-L-threonylglycyl-L-cysteinyl-, cyclic (1→6),(2→10),(5→13)-tris(disulfide)
1422389-17-0
-
MethanesulfonaMide, N-[4-[2-(forMylaMino)acetyl]-5-hydroxy-2-phenoxyphenyl]-
149457-03-4
-
3''-ACETYL-2''-HYDROXY-4-(4-PHENYLBUTOXY)BENZANILIDE
136450-06-1
-
4-Quinazolinamine, N-(3-chloro-4-fluorophenyl)-7-fluoro-6-nitro-
162012-67-1
-
N-Acetyl-L-cysteine
616-91-1
-
([1-PHENYL-METH-(E)-YLIDENE]-AMINO)-ACETIC ACID ETHYL ESTER
40682-54-0
Levothyroxine N,O-bis acetyl impurity 153324-21-1
TOFACITINIB N-ACETYL IMPURITY 477600-76-3
N-Acetyl Linaclotide Impurity 1422389-17-0
N-[4-(2-Formylaminoacetyl)-5-hydroxy-2-phenoxyphenyl]methanesulfonamide 149457-03-4
N-(3-Chloro-4-fluoro-phenyl)-7-fluoro-6-nitro-quinazolin-4-amine 162012-67-1
N-Acetyl-L-cysteine 616-91-1
Ethyl N-benzylideneglycinate 40682-54-0
N,N-Dimethylformamide 68-12-2
(1R,2S)-I-N,N-Diethylnorephedrine Hydrochloride 37025-59-5
N-Hydroxyphthalimide 524-38-9